3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
17
Melanoma
16
Kidney Neoplasms
11
Neoplasm Metastasis
10
Uterine Cervical Neoplasms
9
Prostatic Neoplasms
9
Breast Neoplasms
7
Ovarian Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Anus Neoplasms
6
Vaginal Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Penile Neoplasms
5
Pancreatic Neoplasms
5
Carcinoma, Transitional Cell
5
Carcinoma, Hepatocellular
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Oropharyngeal Neoplasms
4
Lymphoma
4
Lung Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Merkel Cell
4
Vulvar Neoplasms
3
Neuroblastoma
3
Multiple Myeloma
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Wilms Tumor
2
Interventions
valrubicin
1
tretazicar
1
fludarabine
1
Vaccines
1
Oncolytic Virotherapy
1
Mitomycin
1
Interferons
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenoviridae Infections
×
fludarabine
×
Genitourinary
×
Clear all
NCT00625430
2011-07-11
FP253-GDEPT
Biotech Equity Partners Pty Ltd
Phase 1
Unknown
18 enrolled